Patrick M. Beardsley, Ph.D. - Publications

Pharmacology and Toxicology Virginia Commonwealth University, Richmond, VA, United States 
drug abuse, behavioral pharmacology, rat/primate self administration

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Walentiny DM, Komla E, Moisa LT, Mustafa MA, Poklis JL, Akbarali HI, Beardsley PM. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice. Neuropharmacology. 108437. PMID 33316279 DOI: 10.1016/j.neuropharm.2020.108437  0.64
2019 Zheng Y, Obeng S, Reinecke BA, Chen C, Phansalkar PS, Walentiny DM, Gerk PM, Liu-Chen LY, Selley DE, Beardsley PM, Zhang Y. Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder. European Journal of Pharmacology. 172812. PMID 31743739 DOI: 10.1016/j.ejphar.2019.172812  0.64
2019 Younis RM, Taylor RM, Beardsley PM, McClay JL. The gene and its associated phenotypes: focus on CNS drug response. Pharmacogenomics. 20: 669-684. PMID 31250731 DOI: 10.2217/pgs-2019-0015  0.4
2019 Varshneya NB, Walentiny DM, Moisa LT, Walker TD, Akinfiresoye LR, Beardsley PM. Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances. Neuropharmacology. PMID 30904478 DOI: 10.1016/j.neuropharm.2019.03.023  0.64
2019 Walentiny DM, Moisa LT, Beardsley PM. Oxycodone-Like Discriminative Stimulus Effects of Fentanyl-Related Emerging Drugs of Abuse in Mice. Neuropharmacology. PMID 30735691 DOI: 10.1016/j.neuropharm.2019.02.007  0.64
2018 Walentiny DM, Wiebelhaus JM, Beardsley PM. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice. Drug and Alcohol Dependence. 187: 335-342. PMID 29705547 DOI: 10.1016/j.drugalcdep.2018.02.035  0.64
2017 Enga RM, Rice AC, Weller P, Subler MA, Lee D, Hall CP, Windle JJ, Beardsley PM, van den Oord EJ, McClay JL. Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b. Neuroscience Letters. PMID 28115237 DOI: 10.1016/j.neulet.2017.01.044  0.4
2016 Enga RM, Jackson A, Damaj MI, Beardsley PM. Oxycodone physical dependence and its oral self-administration in C57BL/6J mice. European Journal of Pharmacology. PMID 27393461 DOI: 10.1016/j.ejphar.2016.07.006  0.4
2016 Poland RS, Hahn Y, Knapp PE, Beardsley PM, Bowers MS. Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats. Neuropharmacology. PMID 27343385 DOI: 10.1016/j.neuropharm.2016.06.024  0.4
2015 Wiebelhaus JM, Walentiny DM, Beardsley PM. Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on Intracranial Self-Stimulation (ICSS) in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 26491062 DOI: 10.1124/jpet.115.228940  0.64
2015 McClay JL, Vunck SA, Batman AM, Crowley JJ, Vann RE, Beardsley PM, van den Oord EJ. Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 25850894 DOI: 10.1007/s11481-015-9605-1  0.32
2014 Wiley JL, Walentiny DM, Wright MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. European Journal of Pharmacology. 737: 97-105. PMID 24858366 DOI: 10.1016/j.ejphar.2014.05.013  0.4
2014 El-Hage N, Rodriguez M, Podhaizer EM, Zou S, Dever SM, Snider SE, Knapp PE, Beardsley PM, Hauser KF. Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine. Aids (London, England). 28: 1409-19. PMID 24732776 DOI: 10.1097/QAD.0000000000000291  0.4
2014 Beardsley PM, Hauser KF. Glial modulators as potential treatments of psychostimulant abuse. Advances in Pharmacology (San Diego, Calif.). 69: 1-69. PMID 24484974 DOI: 10.1016/B978-0-12-420118-7.00001-9  0.4
2013 Adkins DE, McClay JL, Vunck SA, Batman AM, Vann RE, Clark SL, Souza RP, Crowley JJ, Sullivan PF, van den Oord EJ, Beardsley PM. Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes, Brain, and Behavior. 12: 780-91. PMID 24034544 DOI: 10.1111/gbb.12081  0.4
2013 Aberg KA, Xie LY, McClay JL, Nerella S, Vunck S, Snider S, Beardsley PM, van den Oord EJ. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics. 5: 367-77. PMID 23895651 DOI: 10.2217/epi.13.36  0.32
2013 McClay JL, Adkins DE, Vunck SA, Batman AM, Vann RE, Clark SL, Beardsley PM, van den Oord EJ. Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics : Official Journal of the Metabolomic Society. 9: 392-402. PMID 23554582 DOI: 10.1007/s11306-012-0456-y  0.32
2013 Snider SE, Hendrick ES, Beardsley PM. Glial cell modulators attenuate methamphetamine self-administration in the rat. European Journal of Pharmacology. 701: 124-30. PMID 23375937 DOI: 10.1016/j.ejphar.2013.01.016  0.32
2013 Shelton KL, Hendrick ES, Beardsley PM. Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats. Drug and Alcohol Dependence. 129: 210-6. PMID 23374566 DOI: 10.1016/j.drugalcdep.2013.01.003  0.32
2012 Beardsley PM, Shelton KL. Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.39. PMID 23093352 DOI: 10.1002/0471142301.ns0939s61  0.4
2012 Snider SE, Vunck SA, van den Oord EJ, Adkins DE, McClay JL, Beardsley PM. The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. European Journal of Pharmacology. 679: 75-80. PMID 22306241 DOI: 10.1016/j.ejphar.2012.01.013  0.4
2011 McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ. Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 616-26. PMID 21107309 DOI: 10.1038/npp.2010.193  0.32
2010 Batman AM, Dutta AK, Reith ME, Beardsley PM. The selective dopamine uptake inhibitor, D-84, suppresses cocaine self-administration, but does not occasion cocaine-like levels of generalization. European Journal of Pharmacology. 648: 127-32. PMID 20840845 DOI: 10.1016/j.ejphar.2010.08.051  0.32
2010 Beardsley PM, Shelton KL, Hendrick E, Johnson KW. The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse. European Journal of Pharmacology. 637: 102-8. PMID 20399770 DOI: 10.1016/j.ejphar.2010.04.010  0.32
2010 Beardsley PM, Pollard GT, Howard JL, Carroll FI. Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats. Psychopharmacology. 210: 189-98. PMID 20372878 DOI: 10.1007/s00213-010-1846-3  0.32
2010 Brunzell DH, Boschen KE, Hendrick ES, Beardsley PM, McIntosh JM. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 665-73. PMID 19890263 DOI: 10.1038/npp.2009.171  0.32
2010 Thomas BF, Beardsley PM, Seltzman HH. Current considerations for development of cannabinoid receptor 1 antagonists (Drug Development Research (2009) 70, 8 (525-526) DOI: 10.1002/ddr.20332) Drug Development Research. 71: 159. DOI: 10.1002/ddr.20361  0.32
2009 Kharkar PS, Batman AM, Zhen J, Beardsley PM, Reith ME, Dutta AK. Synthesis and biological characterization of (3R,4R)-4-(2-(benzhydryloxy)ethyl)-1-((R)-2-hydroxy-2-phenylethyl)-piperidin-3-ol and its stereoisomers for activity toward monoamine transporters. Chemmedchem. 4: 1075-85. PMID 19449323 DOI: 10.1002/cmdc.200900085  0.32
2009 Beardsley PM, Thomas BF, McMahon LR. Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. International Review of Psychiatry (Abingdon, England). 21: 134-42. PMID 19367507 DOI: 10.1080/09540260902782786  0.32
2009 Beardsley PM. Evaluation of taranabant (MK-0364) for its self-administration in rhesus monkeys and for its discriminative stimulus effects in rats Drug Development Research. 70: 577-584. DOI: 10.1002/ddr.20336  0.32
2008 Shelton KL, Beardsley PM. Effect of drug-paired exteroceptive stimulus presentations on methamphetamine reinstatement in rats. Pharmacology, Biochemistry, and Behavior. 90: 434-40. PMID 18456312 DOI: 10.1016/j.pbb.2008.03.028  0.32
2006 Vargas-Irwin C, van den Oord EJ, Beardsley PM, Robles JR. A method for analyzing strain differences in acquisition of IV cocaine self-administration in mice. Behavior Genetics. 36: 525-35. PMID 16586151 DOI: 10.1007/s10519-006-9068-5  0.32
2006 Cook CD, Biddlestone L, Coop A, Beardsley PM. Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice. Psychopharmacology. 185: 112-22. PMID 16453156 DOI: 10.1007/s00213-005-0276-0  0.32
2006 Newman JL, Beardsley PM. Effects of memantine, haloperidol, and cocaine on primary and conditioned reinforcement associated with cocaine in rhesus monkeys. Psychopharmacology. 185: 142-9. PMID 16425059 DOI: 10.1007/s00213-005-0282-2  0.32
2006 Vann RE, Balster RL, Beardsley PM. Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats. Psychopharmacology. 184: 482-93. PMID 16001123 DOI: 10.1007/s00213-005-0037-0  0.32
2005 Beardsley PM, Howard JL, Shelton KL, Carroll FI. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology. 183: 118-26. PMID 16184376 DOI: 10.1007/s00213-005-0167-4  0.32
2005 Beardsley PM, Thomas BF. Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. Behavioural Pharmacology. 16: 275-96. PMID 16148435 DOI: 10.1097/00008877-200509000-00003  0.32
2005 Batman AM, Munzar P, Beardsley PM. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Psychopharmacology. 179: 393-401. PMID 15565434 DOI: 10.1007/s00213-004-2035-z  0.32
2004 Shelton KL, Hendrick E, Beardsley PM. Interaction of noncontingent cocaine and contingent drug-paired stimuli on cocaine reinstatement. European Journal of Pharmacology. 497: 35-40. PMID 15302593 DOI: 10.1016/j.ejphar.2004.06.014  0.32
2004 Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS. Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys. Experimental and Clinical Psychopharmacology. 12: 163-72. PMID 15301633 DOI: 10.1037/1064-1297.12.3.163  0.32
2004 Cook CD, Beardsley PM. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists. Behavioural Pharmacology. 15: 75-83. PMID 15075629 DOI: 10.1097/00008877-200402000-00009  0.32
2004 Cook CD, Beardsley PM. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2/3 antagonists. Behavioural Pharmacology. 15: 65-74. PMID 15075628 DOI: 10.1097/00008877-200402000-00008  0.32
2004 Cook CD, Newman JL, Winfree JC, Beardsley PM. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice. Pharmacology, Biochemistry, and Behavior. 77: 309-18. PMID 14751459 DOI: 10.1016/j.pbb.2003.11.002  0.32
2003 Cook CD, Beardsley PM. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice. Pharmacology, Biochemistry, and Behavior. 75: 363-71. PMID 12873628 DOI: 10.1016/S0091-3057(03)00090-X  0.32
2003 Kozikowski AP, Johnson KM, Deschaux O, Bandyopadhyay BC, Araldi GL, Carmona G, Munzar P, Smith MP, Balster RL, Beardsley PM, Tella SR. Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 305: 143-50. PMID 12649362 DOI: 10.1124/jpet.102.046318  0.32
2002 Willmore CB, Bespalov AY, Beardsley PM. Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations. Neurobiology of Learning and Memory. 78: 347-64. PMID 12431422 DOI: 10.1006/nlme.2002.4077  0.32
2002 Beardsley PM, Ratti E, Balster RL, Willetts J, Trist D. The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects. Behavioural Pharmacology. 13: 583-92. PMID 12409996  0.32
2002 Newman JL, Vann RE, May EL, Beardsley PM. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats. Psychopharmacology. 164: 108-14. PMID 12373424 DOI: 10.1007/s00213-002-1198-8  0.32
2002 Cook CD, Carroll FI, Beardsley PM. RTI 113, a 3-phenyltropane analog, produces long-lasting cocaine-like discriminative stimulus effects in rats and squirrel monkeys. European Journal of Pharmacology. 442: 93-8. PMID 12020686 DOI: 10.1016/S0014-2999(02)01501-7  0.32
2002 Cook CD, Aceto MD, Coop A, Beardsley PM. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Psychopharmacology. 160: 99-106. PMID 11862379 DOI: 10.1007/s00213-001-0951-8  0.32
2002 Beardsley PM, Dance ME, Balster RL, Munzar P. Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys. European Journal of Pharmacology. 435: 209-16. PMID 11821028 DOI: 10.1016/S0014-2999(01)01597-7  0.32
2001 Cook CD, Carroll IF, Beardsley PM. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat. Psychopharmacology. 159: 58-63. PMID 11797070 DOI: 10.1007/s002130100891  0.32
2001 Willmore CB, Bespalov AY, Beardsley PM. Competitive and noncompetitive NMDA antagonist effects in rats trained to discriminate lever-press counts. Pharmacology, Biochemistry, and Behavior. 69: 493-502. PMID 11509209 DOI: 10.1016/S0091-3057(01)00568-8  0.32
2001 Bespalov AY, Zvartau EE, Beardsley PM. Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance. Neuroscience and Biobehavioral Reviews. 25: 343-53. PMID 11445139 DOI: 10.1016/S0149-7634(01)00018-5  0.32
2001 Dutta AK, Fei XS, Beardsley PM, Newman JL, Reith ME. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters. Journal of Medicinal Chemistry. 44: 937-48. PMID 11300876 DOI: 10.1021/jm000311k  0.32
2001 Beardsley PM, Sokoloff P, Balster RL, Schwartz JC. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behavioural Pharmacology. 12: 1-11. PMID 11270507  0.32
2000 Bespalov AY, Zvartau EE, Balster RL, Beardsley PM. Effects of N-methyl-D-aspartate receptor antagonists on reinstatement of cocaine-seeking behavior by priming injections of cocaine or exposures to cocaine-associated cues in rats. Behavioural Pharmacology. 11: 37-44. PMID 10821207  0.32
2000 Bespalov AY, Dravolina OA, Zvartau EE, Beardsley PM, Balster RL. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats. European Journal of Pharmacology. 390: 303-11. PMID 10708738 DOI: 10.1016/S0014-2999(99)00927-9  0.32
2000 Beardsley PM, Martin BR. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal. European Journal of Pharmacology. 387: 47-53. PMID 10633159 DOI: 10.1016/S0014-2999(99)00792-X  0.32
1999 Bespalov AY, Balster RL, Beardsley PM. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats. The Journal of Pharmacology and Experimental Therapeutics. 290: 20-7. PMID 10381755  0.32
1999 Bespalov AY, Tokarz ME, Bowen SE, Balster RL, Beardsley PM. Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice. Psychopharmacology. 141: 118-22. PMID 9952035 DOI: 10.1007/s002130050815  0.32
1998 Cook CD, Carroll FI, Beardsley PM. Separation of the locomotor stimulant and discriminative stimulus effects of cocaine by its C-2 phenyl ester analog, RTI-15. Drug and Alcohol Dependence. 50: 123-8. PMID 9649963 DOI: 10.1016/S0376-8716(98)00004-0  0.32
1998 Bespalov AY, Beardsley PM, Balster RL. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats. Pharmacology, Biochemistry, and Behavior. 60: 507-17. PMID 9632234 DOI: 10.1016/S0091-3057(98)00006-9  0.32
1997 Beardsley PM, Harris LS. Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine. Drug and Alcohol Dependence. 48: 77-84. PMID 9363406 DOI: 10.1016/S0376-8716(97)00112-9  0.32
1996 Beardsley PM, Balster RL, Harris LS. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology. 127: 315-22. PMID 8923566 DOI: 10.1007/s002130050092  0.32
1995 Tessari M, Valerio E, Chiamulera C, Beardsley PM. Nicotine reinforcement in rats with histories of cocaine self-administration. Psychopharmacology. 121: 282-3. PMID 8545535 DOI: 10.1007/BF02245640  0.32
1994 Beardsley PM, Lopez OT, Gullikson G, Flynn D. Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats. Alcohol (Fayetteville, N.Y.). 11: 389-95. PMID 7818797 DOI: 10.1016/0741-8329(94)90023-X  0.32
1993 Beardsley PM, Lemaire GA, Meisch RA. Persistence of ethanol self-administration as a function of interreinforcer interval and concentration. Drug and Alcohol Dependence. 34: 71-81. PMID 8174504 DOI: 10.1016/0376-8716(93)90048-U  0.32
1993 Beardsley PM, Balster RL. The effects of delay of reinforcement and dose on the self-administration of cocaine and procaine in rhesus monkeys. Drug and Alcohol Dependence. 34: 37-43. PMID 8174501 DOI: 10.1016/0376-8716(93)90044-Q  0.32
1993 Nevins ME, Nash SA, Beardsley PM. Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice. Psychopharmacology. 110: 92-6. PMID 7870904 DOI: 10.1007/BF02246955  0.32
1993 Chandrakumar NS, Carron CP, Meyer DM, Beardsley PM, Nash SA, Tam LL, Rafferty M. Phenylphosphonate monoester analogs of cocaine. Potential haptens for the generation of catalytic antibodies Bioorganic and Medicinal Chemistry Letters. 3: 309-312. DOI: 10.1016/S0960-894X(01)80899-4  0.32
1992 Beardsley PM, Anthony EW, Lopez OT. Phencyclidine established as a discriminative stimulus using ethanol as a reinforcer. Behavioural Pharmacology. 3: 497-505. PMID 11224152  0.32
1992 Beardsley PM, Balster RL. The intravenous self-administration of antihistamines by rhesus monkeys. Drug and Alcohol Dependence. 30: 117-26. PMID 1353017 DOI: 10.1016/0376-8716(92)90016-6  0.32
1992 Chandrakumar NS, Stapelfeld A, Beardsley PM, Lopez OT, Drury B, Anthony E, Savage MA, Williamson LN, Reichman M. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions. Journal of Medicinal Chemistry. 35: 2928-38. PMID 1323677  0.32
1990 Beardsley PM, Hayes BA, Balster RL. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 252: 953-9. PMID 2181113  0.32
1989 Knisely JS, Beardsley PM, Aceto MD, Balster RL, Harris LS. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor. Drug and Alcohol Dependence. 23: 143-51. PMID 2702924 DOI: 10.1016/0376-8716(89)90020-3  0.32
1989 Woolverton WL, Ator NA, Beardsley PM, Carroll ME. Effects of environmental conditions on the psychological well-being of primates: a review of the literature. Life Sciences. 44: 901-17. PMID 2648097 DOI: 10.1016/0024-3205(89)90489-X  0.32
1988 Beardsley PM, Balster RL. Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine. The Journal of Pharmacology and Experimental Therapeutics. 244: 34-40. PMID 3336008  0.32
1988 Balster R, Willetts J, Beardsley P, Hayes B, Rice A. Excitatory amino acid neurotransmission and the behavioral pharmacology of phencyclidine-like drugs Nida Research Monograph Series. 49.  0.32
1987 Beardsley PM, Balster RL. Behavioral dependence upon phencyclidine and ketamine in the rat. The Journal of Pharmacology and Experimental Therapeutics. 242: 203-11. PMID 3612525  0.32
1987 Beardsley PM, Balster RL. Self-administration of minaprine in rhesus monkeys. Drug and Alcohol Dependence. 19: 121-9. PMID 3582164 DOI: 10.1016/0376-8716(87)90050-0  0.32
1987 Beardsley PM, Balster RL, Salay JM. Separation of the response rate and discriminative stimulus effects of phencyclidine: training dose as a factor in phencyclidine-saline discrimination. The Journal of Pharmacology and Experimental Therapeutics. 241: 159-65. PMID 3572780  0.32
1987 Beardsley PM, Scimeca JA, Martin BR. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 241: 521-6. PMID 3033218  0.32
1987 Martin BR, Compton DR, Little PJ, Martin TJ, Beardsley PM. Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids. Nida Research Monograph. 79: 108-22. PMID 2830532  0.32
1986 Beardsley PM, Balster RL, Harris LS. Dependence on tetrahydrocannabinol in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 239: 311-9. PMID 3021952  0.32
1986 Beardsley PM, Balster RL, Harris LS. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug and Alcohol Dependence. 18: 149-57. PMID 2877842 DOI: 10.1016/0376-8716(86)90047-5  0.32
1984 Beardsley PM, Balster RL, Harris LS. Behavioral dependence in rhesus monkeys following chronic THC administration. Nida Research Monograph. 55: 111-7. PMID 6100502  0.32
1984 Beardsley PM, Balster RL, Harris LS. Behavioral dependence of Rhesus monkeys on intravenously-administered delta 9-tetrahydrocannabinol Federation Proceedings. 43: no. 3905.  0.32
1983 Beardsley PM, Lemaire GA, Meisch RA. Effects of minimum-interreinforcer interval on ethanol-maintained performance of rats. Pharmacology, Biochemistry, and Behavior. 19: 843-7. PMID 6647519 DOI: 10.1016/0091-3057(83)90091-6  0.32
1982 Uren JR, Hargis BJ, Beardsley P. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase Cancer Research. 42: 4068-4071. PMID 7105004  0.32
1982 Beardsley P, Klaus M. Methylation of arabinosyl cytosine (araC) residues in DNA Pediatric Research. 16: No. 720.  0.32
1981 Beardsley PM, Meisch RA. A precision drinking device for rats tested with water, etonitazene, and ethanol. Pharmacology, Biochemistry, and Behavior. 14: 871-6. PMID 6114498 DOI: 10.1016/0091-3057(81)90376-2  0.32
1980 Kufe DW, Beardsley P, Karp D, Parker L, Rosowsky A, Canellos G, Frei IIIrd E. High-dose thymidine infusions in patients with leukemia and lymphoma Blood. 55: 580-589. PMID 6965595  0.32
1978 Beardsley PM, Lemaire GA, Meisch RA. Ethanol-reinforced behavior of rats with concurrent access to food and water. Psychopharmacology. 59: 7-11. PMID 100816 DOI: 10.1007/BF00428023  0.32
Show low-probability matches.